Navigation Links
UNT System Names Jacobson Founding Dean of College of Pharmacy
Date:1/25/2012

FORT WORTH, Texas, Jan. 25, 2012 /PRNewswire-USNewswire/ -- UNT Health Science Center President Scott Ransom, DO, announced today the appointment of Myron (Mike) Jacobson, Ph.D., as the founding dean of the UNT System College of Pharmacy. "After a national search we were very pleased to recruit a renowned expert on translational pharmaceutics, chemistry and research, an experienced academic leader in pharmacy education, and a successful entrepreneur and businessman," Ransom said.

"With the support of many key area legislators, the 82nd Legislature approved a UNT System College of Pharmacy to be supported by all of our campuses," said UNT System Chancellor Lee Jackson. "This new program will be headquartered in Fort Worth. It is also a great benefit that Mike is familiar with the UNT Health Science Center from his prior experience in Fort Worth."

Jacobson, most recently a professor of Medicinal Chemistry in the College of Pharmacy at the University of Arizona, Tucson, and a member of the Arizona Cancer Center, received a Bachelor of Science degree in Chemistry from the University of Wisconsin, Platteville; a Ph.D. in biochemistry from Kansas State University; and completed postdoctoral research at the University of Utah and at the Mayo Clinic before joining the University of North Texas (formerly North Texas State University) in 1974.

Jacobson joined the UNT Health Science Center at Fort Worth (UNTHSC) in 1984 and served as acting chairman of the Department of Anatomy and Cell Biology from 1989 to 1992. In 1992, he was appointed chairman of Medicinal Chemistry and Pharmaceutics at the College of Pharmacy at the University of Kentucky.  He joined the faculty of the University of Arizona in 2000.

Jacobson's research, in collaboration with his wife, Elaine Jacobson, Ph.D., has focused on the effect of niacin and niacin-derived molecules on human health.  In the late 1990s, their efforts to translate knowledge of niacin function toward clinical applications led to the founding of Niadyne, Inc. Niadyne is currently a family of three biotechnology companies: Niadyne, which currently markets consumer skin care products in multiple distribution channels; Niadyne Pharma, involved in pharmaceutical products for dermatology; and Niadyne Cardiology, involved in cardiovascular health products.  With more than 30 years of National Institutes of Health funding, his research has contributed to new skin cancer prevention and treatments.

In 2011, StriVectin skin damage repair products based on technology developed by the Jacobsons received the Skin Sense award from the Skin Cancer Foundation

UNT Health Science Center Provost Thomas Yorio, Ph.D., said the addition of the new pharmacy program is an important addition to the center's plan to create a comprehensive health science center, and Jacobson's appointment is a critical step.  "Dr. Jacobson is already hard at work forging strong relationships with all of our schools, and I am proud to have him as the founding dean."

The UNT System College of Pharmacy is scheduled to matriculate its first class of Doctor of Pharmacy students in 2013.  UNT in Denton and UNT Dallas are developing plans to collaborate with the College of Pharmacy and to expand pre-pharmacy undergraduate programs, graduate programs in pharmaceutical sciences, and provide housing for clinical programs in conjunction with hospitals throughout the region.

The University of North Texas System comprises three institutions – the University of North Texas, UNT Dallas and the UNT Health Science Center – with a total enrollment of more than 37,000 students. The system's flagship campus, UNT, is a thriving, student-focused public research university in Denton with a legacy of excellence in a broad range of academic areas.  UNT Dallas is the first public university in the city limits of Dallas. The UNT Health Science Center in Fort Worth trains physicians and other professionals through its Texas College of Osteopathic Medicine, Graduate School of Biomedical Sciences, School of Public Health and School of Health Professions.

 

 


'/>"/>
SOURCE The University of North Texas System
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
5. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
6. New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects
7. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
8. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
9. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
10. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
11. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... NEW YORK , April 28, 2016 /PRNewswire/ ... will notably complement the company,s valve repair and ... the move also places Abbott more firmly into ... one of the fastest growing device areas, with ... to its recent report,  Advanced Remote Patient ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... , April 28, 2016  The blood testing ... million dollars, according to Kalorama Information and The Freedonia ... immunoassays and nucleic acid testing.  The healthcare research firm ... progress in developing blood collection stations and in improving ... in Kalorama Information,s report, Blood Testing Market ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... May 03, 2016 , ... California health startup Pegara ... that helps people assess their risk of developing Alzheimer’s disease. Using a questionnaire ... a “Risk Reduction Score™” that summarizes how their lifestyle choices may affect their ...
(Date:5/3/2016)... ... 03, 2016 , ... SELEX (systematic evolution of ligands ... random library of sequences depending on their attraction for a target molecule. These ... is commonly performed using filters, panning, or affinity chromatography separations. However, these traditional ...
(Date:5/3/2016)... ... May 03, 2016 , ... Elizabeth Murray has always loved walking ... her with one on her shoulder and one on her arm. But she got ... of years of mitral valve prolapse. , The valves of the heart wouldn’t close ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... has been selected by Tidelands Health, a three hospital system in South Carolina, ... constantly on the lookout for technology that enhances communication, drives workflow efficiencies and ...
(Date:5/3/2016)... ... May 03, 2016 , ... Each year, about 800,000 ... of death across the United States and account for one death every four minutes. ... or are permanently disabled. HCR ManorCare is launching a video series called “Your Brain,” ...
Breaking Medicine News(10 mins):